Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

FDA approves Gileads Liver Drug Livdelzi

Gilead announced FDAs approval of Livdelzi (Seladelpar) for treatment of PBC, a rare, chronic, autoimmune

Qvents
August 18, 2024

FDA Approves Pfizer’s VELSIPITY  (etr

Velsipity (etrasimod) is an oral, once-daily, 2mg dose medication for adults with moderately to severely

Qvents
October 17, 2023

FDA approves Cantharidin (YCANTH™,  V

Verrica Pharmaceuticals Inc. is a dermatology therapeutics company developing medications for skin diseases requiring medical

Qvents
July 25, 2023

USFDA grants full approval for Pfizers P

Qvents
May 29, 2023